Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Date:3/7/2013

operating margin18.7%

18.6%17.9%

20.6%Adjustments:Share-based compensation3,409

3,107

9.7%14,314

11,473

24.8%Amortization of acquired intangible assets408

484

(15.7%)1,983

1,549

28.0%Revaluation of contingent consideration(3,391)

-

NA(3,391)

-

NAImpairment charges for goodwill and intangible assets3,415

-

NA3,415

-

NANon-GAAP operating income27,398

23,803

15.1%105,740

96,832

9.2%Non-GAAP operating margin21.8%

21.9%21.2%

23.8%GAAP net income23,821

23,481

1.4%86,584

80,979

6.9%GAAP net margin19.0%

21.6%17.3%

19.9%Adjustments:Share-based compensation3,409

3,107

9.7%14,314

11,473

24.8%Amortization of acquired intangible assets408

484

(15.7%)1,983

1,549

28.0%Deferred tax impact related to acquired intangible assets(150)

(137)

9.5%(734)

(591)

24.2%Revaluation of contingent consideration(3,391)

-

NA(3,391)

-

NAImpairment charges for goodwill and intangible assets3,415

-

NA3,415

-

NANon-GAAP net income27,512

26,935

2.1%102,171

93,410

9.4%Non-GAAP net margin21.9%

24.8%20.4%

22.9%GAAP net income23,821

23,481

1.4%86,584

80,979

6.9%Add back:Depreciation and amortization11,468

9,361

22.5%41,672

33,997

22.6%Interest (income) expenses, net(1,487)

(1,819)

(18.3%)(6,010)

(5,266)

14.1%Income tax expenses (benefit)4,508

3,917

15.1%17,393

16,606

4.7%EBITDA38,310

34,940

9.6%139,639

126,316

10.5%Adjustments:Sh
'/>"/>

SOURCE Wuxi PharmaTech Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
2. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
3. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
4. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
5. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
8. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
11. WuXi PharmaTech Announces First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... DIEGO and CARDIFF-BY-THE-SEA, Calif. ... Inc. (NASDAQ: SRNE ;  Sorrento), an ... associated pain, and Conkwest, Inc., a privately-held immuno-oncology ... Natural Killer (NK) cell-line based therapy, announced today ... agreement to jointly develop next generation CAR-TNK™ (pronounced ...
(Date:12/19/2014)... 18, 2014  Decision Resources Group finds that the ... will increase to a value of over ... by expansion in the large direct energy device market. ... increasingly adopted due to the advantages they offer and ... findings from Decision Resources Group,s coverage of the U.S. ...
(Date:12/19/2014)... KANSAS CITY, Kan. , Dec. 18, 2014 ... PETX ), a biopharmaceutical company focused on ... for companion animals, today announced positive results from ... company,s innovative drug for treating pain in dogs ... demonstrated improvements in pain assessment scores that were ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... University Medical Pharmaceuticals, which specializes in developing and distributing ... to the mass market, announced today that it has ... , Mr. Ten brings 28 years of ... luxury and consumer packaged goods industry. At University ...
... Inc., a company leading the scientific research of neurogenesis ... identify novel pathways for the treatment of central nervous ... Scolnick from the Broad Institute of MIT and Harvard ... to its scientific advisory board. The appointees join BrainCells, ...
Cached Medicine Technology:University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales 2University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales 3BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman 2BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman 3
(Date:12/20/2014)... (PRWEB) December 20, 2014 DePuy ... a metal-on-metal version of the artificial hip system ... state and federal courts, Bernstein Liebhard LLP reports. ... Bergen County Superior Court on December 2nd, counsel ... begin deposition of plaintiffs on November 19, 2014, ...
(Date:12/20/2014)... Recently, VogueQueen.com, a leading wedding dress wholesaler and retailer, ... for 2015. Great discounts are now offered on all ... get a discount, up to 80% off, when they ... 30, 2015. , VogueQueen.com has recently released its new ... promotion. Many customers worldwide like VogueQueen’s special designs which ...
(Date:12/20/2014)... 20, 2014 As Risperdal lawsuits ... in U.S. courts, Bernstein Liebhard LLP notes the ... children treated with the medication may experience elevated ... development and lactation. The study, which appears in ... adolescents who began treatment with risperidone, an antipsychotic ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer (called ... Christmas. In the promotion, all buyers worldwide can enjoy ... something special for the women who are looking for ... new collections of 2015 dresses have been unveiled recently. ... discounted prices. Visit our website now before they are ...
(Date:12/20/2014)... The Twin Cities DI Day is recognized as ... Over 250 financial professionals come together each year to ... get motivated to protect their clients and to be ... the challenges of disability. , On September 23rd, 2014, ... to attend The 13th Annual Twin Cities DI Day ...
Breaking Medicine News(10 mins):Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3
... , DETROIT, Dec. 11 Blue Cross Blue ... the health of millions of Michigan residents by passing ... "Limiting people,s exposure to secondhand smoke is a positive ... care costs," said BCBSM Corporate Communications Vice President Andy ...
... PITTSBURGH, Dec. 11 UPMC Health Plan announced today that it ... Posit Science®, at no cost, to all UPMC for Life ... part of the UPMC Health Plan wellness services, which focus on ... as the Insight(TM) Brain Fitness Program , is a suite ...
... , CHICAGO, Dec. 11 Chicago Bears, quarterback Jay ... 44 children to American Diabetes Association diabetes camps next summer - ... Touchdowns for Diabetes campaign, Lilly donates money to the American Diabetes ... pass completions in the 2009 season - $1,000 per touchdown (roughly ...
... This release is available in German . ... size of an apartment block and is located on the site ... that of the earth are kept out here as effective as ... fields of, e.g., the human heart. This was the motivation ...
... ... health insurance carriers to succeed in a post-health care reform environment. , ... Atlanta, GA (PRWEB) December ... automation solutions to the health insurance industry, has launched a new package of products ...
... Studies also report on statin dosages and lifestyle factors that ... Blood levels of LDL cholesterol, the bad kind that blocks ... menopause, but there are no other dramatic changes in risk ... new study has found. , "This suggests that as women ...
Cached Medicine News:Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 2Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 3Health News:Bears Quarterback Jay Cutler and Eli Lilly and Company Will Send 44 Kids to American Diabetes Association Camps Through the Touchdowns for Diabetes Campaign 2Health News:Bears Quarterback Jay Cutler and Eli Lilly and Company Will Send 44 Kids to American Diabetes Association Camps Through the Touchdowns for Diabetes Campaign 3Health News:Bears Quarterback Jay Cutler and Eli Lilly and Company Will Send 44 Kids to American Diabetes Association Camps Through the Touchdowns for Diabetes Campaign 4Health News:Magnetic field measurements of the human heart at room temperature 2Health News:Magnetic field measurements of the human heart at room temperature 3Health News:Connecture, Inc. Launches New Technology Package to Increase Health Insurance Carriers' Success in the Online Individual Market 2Health News:Menopause Often Means Worsening Cholesterol 2Health News:Menopause Often Means Worsening Cholesterol 3
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. All SheerVision ...
... Experience the finest surgical-quality loupes available ... the standard for innovative optical design, ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. All ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. All SheerVision loupes ...
Medicine Products: